Dave Lennon, PhD - 2021 World Medical Innovation Forum
May 2–4, 2022
Dave Lennon
This speaker appears at this event:

Dave Lennon, PhD

President, Novartis Gene Therapies

Dave Lennon has served as President of Novartis Gene Therapies (formerly AveXis), since June 2018. He leads the organization in its mission to bring gene therapy to patients and families devastated by rare and life-threatening neurological genetic diseases, starting with the company’s proprietary gene therapy for spinal muscular atrophy.
Dave has been with Novartis since 2005, serving as Oncology General Manager in Japan and overseeing the company’s extensive portfolio in cancer, including hematology, solid tumors and cell and gene therapies. Prior to that, he served as Vice President, U.S. Solid Tumors Franchise.
Dave has also held leadership positions in the Novartis Pharmaceuticals division, including global therapeutic head positions and sales and marketing operating roles in the U.S. He has extensive experience in neuroscience, immunology, cardiovascular and rare diseases, and served as Chief Marketing Officer, Greater China Region.
Prior to Novartis, Dave worked as an Associate Principal at McKinsey & Company.
Dave holds a B.A. in biophysics from Columbia University and a Ph.D. in cell biology from Weill Medical College at Cornell University.

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA